Skip to main content
Loading

Immunotherapy for autoimmune disease: from bulk depletion to precision medicine

25 Sep 2025
Translational Immunology
  • CAR T cell therapy: CD19 or other B cell subsets? discussion of CAR targets
  • NK cells: natural control of autoreactive cells
  • Beyond CD20: emerging targeted mAb therapy for autoimmune disease 
Industry Expert
Stefanie Mandl-Cashman, Chief Science Officer - Indapta Therapeutics